OTLC — Oncotelic Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Oncotelic Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.082	0.474	0.569	0.241	0.17
Net Total Accounts Receivable
Net Total Receivables	0.15	0.02	0.02	0.02	0.019
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.273	0.616	0.627	0.303	0.272
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.048	0.01	0	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	23.7	23.7	23.6	36.1	30
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.78	11.2	15.5	16.9	16.5
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	6.78	11.9	15.7	16.7	17.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	16.9	11.8	7.96	19.4	12.1
Total Liabilities & Shareholders' Equity	23.7	23.7	23.6	36.1	30
Total Common Shares Outstanding
Total Preferred Shares Outstanding